ChemoMetec A/S (CHEMM.CO)
DKK 483.0
(0.12%)
DKK 483.0
(0.12%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 4.15 Million DKK | -41.97% |
| 2023 | 7.16 Million DKK | 5.39% |
| 2022 | 6.79 Million DKK | 188.13% |
| 2021 | 2.35 Million DKK | 2.92% |
| 2020 | 2.29 Million DKK | -87.81% |
| 2019 | 18.79 Million DKK | -6.52% |
| 2018 | 20.1 Million DKK | -8.0% |
| 2017 | 21.85 Million DKK | -1.69% |
| 2016 | 22.22 Million DKK | 183.79% |
| 2015 | 7.83 Million DKK | 346.32% |
| 2014 | 1.75 Million DKK | -30.96% |
| 2013 | 2.54 Million DKK | -24.88% |
| 2012 | 3.38 Million DKK | -17.72% |
| 2011 | 4.11 Million DKK | -45.71% |
| 2010 | 7.57 Million DKK | 62.47% |
| 2009 | 4.66 Million DKK | 0.0% |
| 2008 | - DKK | -100.0% |
| 2007 | 2.79 Million DKK | 0.0% |
| 2006 | - DKK | 0.0% |
| 2005 | - DKK | -100.0% |
| 2004 | 510 Thousand DKK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 5.94 Million DKK | 59.85% |
| 2024 Q4 | 4.15 Million DKK | 212.17% |
| 2024 Q1 | 3.72 Million DKK | -48.03% |
| 2024 FY | 4.15 Million DKK | -41.97% |
| 2024 Q3 | 1.33 Million DKK | -77.62% |
| 2023 FY | 7.16 Million DKK | 5.39% |
| 2023 Q1 | 5.45 Million DKK | -19.74% |
| 2023 Q4 | 7.16 Million DKK | 53.85% |
| 2023 Q2 | 7.94 Million DKK | 45.7% |
| 2023 Q3 | 4.65 Million DKK | -41.42% |
| 2022 FY | 6.79 Million DKK | 188.13% |
| 2022 Q1 | 4.13 Million DKK | 75.4% |
| 2022 Q3 | 5.88 Million DKK | -1.47% |
| 2022 Q2 | 5.97 Million DKK | 44.41% |
| 2022 Q4 | 6.79 Million DKK | 15.45% |
| 2021 Q1 | 1.16 Million DKK | -49.28% |
| 2021 Q3 | 1.5 Million DKK | -15.6% |
| 2021 Q4 | 2.35 Million DKK | 56.78% |
| 2021 FY | 2.35 Million DKK | 2.92% |
| 2021 Q2 | 1.78 Million DKK | 53.36% |
| 2020 Q1 | 3.01 Million DKK | -83.98% |
| 2020 Q2 | 3.01 Million DKK | 0.0% |
| 2020 FY | 2.29 Million DKK | -87.81% |
| 2020 Q4 | 2.29 Million DKK | 41.95% |
| 2020 Q3 | 1.61 Million DKK | -46.4% |
| 2019 Q3 | 18.79 Million DKK | -4.94% |
| 2019 Q4 | 18.79 Million DKK | 0.0% |
| 2019 FY | 18.79 Million DKK | -6.52% |
| 2019 Q2 | 19.77 Million DKK | 1.28% |
| 2019 Q1 | 19.52 Million DKK | -2.9% |
| 2018 Q3 | 19.86 Million DKK | -24.19% |
| 2018 FY | 20.1 Million DKK | -8.0% |
| 2018 Q4 | 20.1 Million DKK | 1.23% |
| 2018 Q1 | 23.84 Million DKK | 9.09% |
| 2018 Q2 | 26.19 Million DKK | 9.89% |
| 2017 Q1 | 21.88 Million DKK | -1.54% |
| 2017 Q3 | 21.58 Million DKK | -2.54% |
| 2017 Q2 | 22.14 Million DKK | 1.2% |
| 2017 FY | 21.85 Million DKK | -1.69% |
| 2017 Q4 | 21.85 Million DKK | 1.24% |
| 2016 Q2 | 22.64 Million DKK | 1.55% |
| 2016 FY | 22.22 Million DKK | 183.79% |
| 2016 Q3 | 21.98 Million DKK | -2.92% |
| 2016 Q4 | 22.22 Million DKK | 1.11% |
| 2016 Q1 | 22.29 Million DKK | 184.68% |
| 2015 Q1 | 5.53 Million DKK | 215.44% |
| 2015 FY | 7.83 Million DKK | 346.32% |
| 2015 Q4 | 7.83 Million DKK | 9.55% |
| 2015 Q2 | 5.53 Million DKK | 0.0% |
| 2015 Q3 | 7.15 Million DKK | 29.15% |
| 2014 Q3 | 927 Thousand DKK | -31.13% |
| 2014 FY | 1.75 Million DKK | -30.96% |
| 2014 Q1 | 1.34 Million DKK | -47.05% |
| 2014 Q4 | 1.75 Million DKK | 89.32% |
| 2014 Q2 | 1.34 Million DKK | 0.0% |
| 2013 Q1 | 846 Thousand DKK | -75.0% |
| 2013 Q2 | - DKK | -100.0% |
| 2013 Q3 | 1.75 Million DKK | 0.0% |
| 2013 Q4 | 2.54 Million DKK | 44.76% |
| 2013 FY | 2.54 Million DKK | -24.88% |
| 2012 Q4 | 3.38 Million DKK | 300.0% |
| 2012 Q1 | 1.02 Million DKK | -75.0% |
| 2012 Q3 | 846 Thousand DKK | 0.0% |
| 2012 Q2 | - DKK | -100.0% |
| 2012 FY | 3.38 Million DKK | -17.72% |
| 2011 FY | 4.11 Million DKK | -45.71% |
| 2011 Q4 | 4.11 Million DKK | 300.0% |
| 2011 Q2 | - DKK | -100.0% |
| 2011 Q1 | 1.89 Million DKK | -75.0% |
| 2011 Q3 | 1.02 Million DKK | 0.0% |
| 2010 Q3 | 1.89 Million DKK | 62.47% |
| 2010 Q4 | 7.57 Million DKK | 300.0% |
| 2010 FY | 7.57 Million DKK | 62.47% |
| 2010 Q1 | 1.16 Million DKK | 0.0% |
| 2010 Q2 | 1.16 Million DKK | 0.0% |
| 2009 Q2 | - DKK | 0.0% |
| 2009 Q4 | 1.16 Million DKK | 0.0% |
| 2009 FY | 4.66 Million DKK | 0.0% |
| 2009 Q1 | - DKK | 0.0% |
| 2009 Q3 | 1.16 Million DKK | 0.0% |
| 2008 Q4 | - DKK | 0.0% |
| 2008 Q3 | - DKK | -100.0% |
| 2008 Q2 | 699.25 Thousand DKK | 0.0% |
| 2008 Q1 | 699.25 Thousand DKK | 0.0% |
| 2008 FY | - DKK | -100.0% |
| 2007 Q4 | 699.25 Thousand DKK | 0.0% |
| 2007 Q2 | - DKK | 0.0% |
| 2007 Q3 | 699.25 Thousand DKK | 0.0% |
| 2007 Q1 | - DKK | 0.0% |
| 2007 FY | 2.79 Million DKK | 0.0% |
| 2006 Q1 | - DKK | 0.0% |
| 2006 Q2 | - DKK | 0.0% |
| 2006 Q3 | - DKK | 0.0% |
| 2006 FY | - DKK | 0.0% |
| 2006 Q4 | - DKK | 0.0% |
| 2005 Q4 | - DKK | 0.0% |
| 2005 Q3 | - DKK | -100.0% |
| 2005 Q2 | 127.5 Thousand DKK | 0.0% |
| 2005 FY | - DKK | -100.0% |
| 2005 Q1 | 127.5 Thousand DKK | 0.0% |
| 2004 FY | 510 Thousand DKK | 0.0% |
| 2004 Q3 | 127.5 Thousand DKK | 0.0% |
| 2004 Q4 | 127.5 Thousand DKK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ambu A/S | 584 Million DKK | 99.289% |
| Demant A/S | 14.45 Billion DKK | 99.971% |
| GN Store Nord A/S | 13.49 Billion DKK | 99.969% |
| Scandinavian Medical Solutions A/S | 28.6 Million DKK | 85.474% |
| ViroGates A/S | 5.3 Million DKK | 21.604% |